302964-24-5 Usage
Description
2-Amino-N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide, also known as TMC-120, is a thiazole derivative with a molecular formula of C11H10ClN3OS and a molecular weight of 265.7 g/mol. It is a yellow solid substance that exhibits potential medicinal properties, such as antifungal and antimicrobial activities. TMC-120 is primarily used in the pharmaceutical industry and is being investigated for its potential in treating various diseases and infections. 2-Amino-N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide is synthesized through chemical reactions and processes in a laboratory setting.
Uses
Used in Pharmaceutical Industry:
2-Amino-N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide is used as a pharmaceutical compound for its antifungal and antimicrobial properties. It is being explored for its potential in treating various diseases and infections, making it a promising candidate for medicinal applications.
Used in Antifungal Applications:
In the pharmaceutical industry, 2-Amino-N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide is used as an antifungal agent to combat fungal infections. Its ability to inhibit fungal growth makes it a valuable component in the development of antifungal medications.
Used in Antimicrobial Applications:
2-Amino-N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide is also used as an antimicrobial agent in the pharmaceutical industry. Its potential to inhibit the growth of bacteria and other microorganisms contributes to the development of new antimicrobial drugs and treatments.
Used in Disease and Infection Treatment Research:
In the pharmaceutical industry, 2-Amino-N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide is used as a research compound for exploring its potential in treating various diseases and infections. Its unique properties and activities make it a valuable asset in the search for new therapeutic solutions.
Check Digit Verification of cas no
The CAS Registry Mumber 302964-24-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,0,2,9,6 and 4 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 302964-24:
(8*3)+(7*0)+(6*2)+(5*9)+(4*6)+(3*4)+(2*2)+(1*4)=125
125 % 10 = 5
So 302964-24-5 is a valid CAS Registry Number.
InChI:InChI=1/C15H17N3O/c1-9-6-10(2)14(11(3)7-9)18-15(19)12-4-5-17-8-13(12)16/h4-8H,16H2,1-3H3,(H,18,19)
302964-24-5Relevant articles and documents
SUBSTITUTED ARYLUREA COMPOUNDS FOR INDUCING APOPTOSIS AND COMPOSITION FOR ANTICANCER COMPRISING THE SAME
-
, (2021/08/17)
The present invention relates to a substituted arylurea compound inducing apoptosis and an anticancer composition comprising the same. The present invention relates to a novel compound capable of preventing, treating and alleviating cancer diseases such as prostate cancer, breast cancer, lung cancer, colorectal cancer, and skin cancer by inhibiting apoptosis of cancer cells and inhibiting proliferation of cancer cells.
Preparation process of dasatinib
-
Paragraph 0055; 0056-0064; 0081; 0082; 0083; 0084-0086, (2019/06/27)
The invention relates to a preparation process of dasatinib. The preparation process includes the following steps that 3-ethyl propionate reacts with 2-chlorine-6-methylaniline under an alkaline condition to obtain a compound 3; the compound 3, copper bromide and thiourea react under action of hydroxyethyl-beta-cyclodextrin to obtain 2-amino-N-(2-chlorine-6-methyl phenyl) thiazole-5-formamide through a heating reaction; secondly, 4,6-dichloro-2-methyl pyrimidine reacts with N-hydroxyethyl piperazine, 2-amino-N-(2-chloro-6-methyl phenyl) thiazole-5-formamide sequentially in the presence of alkali, a catalytic system and an organic solvent, and a compound 1, namely dasatinib, is obtained. The conditions are mild, the steps are simple, the process is environmentally friendly, the yield is high, and the process is suitable for industrial production.
Preparation method of dasatinib intermediate
-
Paragraph 0041-0048; 0053; 0054, (2019/04/04)
The invention relates to a preparation method of a dasatinib intermediate. The method comprises the following steps: performing heating reflux on ethyl 3-oxopropanoate and 2-chloro-6-methylaniline under alkaline conditions, adding copper bromide, and performing warming reflux to obtain a compound 2; and cyclizing the compound 2 and thiourea in a solvent PEG 400 to obtain a target product, namely 2-amino-N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide. The method involved in the invention has mild conditions, simple steps, environmental friendliness and high yield, and is suitable for industrial production.